{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:07:59Z","timestamp":1789661279403,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.esmogo.2026.100405","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:45:08Z","timestamp":1789659908000},"page":"100405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Care delivery among patients with early-onset versus average-onset cholangiocarcinoma: a nationwide retrospective analysis"],"prefix":"10.1016","volume":"14","author":[{"given":"U.S.","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3218-4736","authenticated-orcid":false,"given":"A.","family":"Nottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.T.","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3918-3954","authenticated-orcid":false,"given":"S.J.","family":"Concors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-8236","authenticated-orcid":false,"given":"N.J.","family":"Hornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-4639","authenticated-orcid":false,"given":"T.J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9696-6122","authenticated-orcid":false,"given":"A.","family":"Lamarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-0863","authenticated-orcid":false,"given":"J.W.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmogo.2026.100405_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","article-title":"Cholangiocarcinoma 2026: status quo, unmet needs and priorities","volume":"23","author":"Banales","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.esmogo.2026.100405_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","article-title":"Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017","volume":"27","author":"Javle","year":"2022","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.esmogo.2026.100405_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.esmogo.2026.100405_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/14737140.2024.2387612","article-title":"Targeted therapies in advanced biliary malignancies: a clinical review","volume":"24","author":"Grewal","year":"2024","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.esmogo.2026.100405_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2024.07.005","article-title":"Characteristics and outcomes of patients with early-onset vs average-onset cholangiocarcinoma in the United States","author":"Grewal","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.esmogo.2026.100405_bib6","article-title":"The Cholangiocarcinoma in the Young (CITY) study: tumor biology, treatment patterns, and survival outcomes in adolescent young adults with cholangiocarcinoma","volume":"7","author":"Pappas","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2026.100405_bib7","article-title":"Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: a systematic review and meta-analysis","volume":"8","author":"Akkus","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.esmogo.2026.100405_bib8","article-title":"Molecular differences with therapeutic implications in early-onset compared with average-onset biliary tract cancers","volume":"8","author":"Jayakrishnan","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2026.100405_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.amjsurg.2015.08.031","article-title":"Rectal cancer in patients under the age of 50 years: the delayed diagnosis","volume":"211","author":"Scott","year":"2016","journal-title":"Am J Surg"},{"issue":"11","key":"10.1016\/j.esmogo.2026.100405_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/codi.70285","article-title":"Listening to patients: a qualitative study on diagnostic delay, coping strategies and stigma in early-onset colorectal cancer","volume":"27","author":"Gros","year":"2025","journal-title":"Colorectal Dis"},{"issue":"5","key":"10.1016\/j.esmogo.2026.100405_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmogo.2026.100405_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jss.2023.11.067","article-title":"Surgical resection alone is associated with higher long-term survival than multiagent chemotherapy alone for patients with localized biliary tract cancers","volume":"295","author":"Elshami","year":"2024","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.esmogo.2026.100405_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"issue":"10391","key":"10.1016\/j.esmogo.2026.100405_bib14","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.esmogo.2026.100405_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2217\/fon-2023-0151","article-title":"Diagnostic journey and life impact of cholangiocarcinoma: results from surveys of patient and caregiver experiences","volume":"20","author":"Bibeau","year":"2024","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2026.100405_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12029-022-00820-4","article-title":"The implications of treatment delays in adjuvant therapy for resected cholangiocarcinoma patients","volume":"54","author":"Parsons","year":"2023","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2026.100405_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.surg.2023.03.011","article-title":"An analysis of time to treatment in patients with pancreatic adenocarcinoma","volume":"174","author":"Sugumar","year":"2023","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.esmogo.2026.100405_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jadohealth.2020.04.017","article-title":"Results of a national text message poll of youth: perspectives on primary care","volume":"67","author":"DeJonckheere","year":"2020","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.esmogo.2026.100405_bib19","article-title":"Breaking barriers: enhancing cancer detection in younger patients by overcoming diagnostic bias in primary care","volume":"11","author":"Jerjes","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.esmogo.2026.100405_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s12967-022-03719-7","article-title":"Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study","volume":"20","author":"Min","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.esmogo.2026.100405_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104427","article-title":"Diagnostic delay in women with cancer: What do we know and which factors contribute?","volume":"80","author":"Hoveling","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.esmogo.2026.100405_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/285096","article-title":"Missed opportunities for the diagnosis of colorectal cancer","volume":"2015","author":"Siminoff","year":"2015","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.esmogo.2026.100405_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30997","article-title":"Time to diagnosis among young patients with cancer","volume":"71","author":"Winestone","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.esmogo.2026.100405_bib24","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.21037\/tcr-20-2506","article-title":"The correlations between socioeconomic status and intrahepatic cholangiocarcinoma in the United States: a population-based study","volume":"9","author":"Zhu","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"2","key":"10.1016\/j.esmogo.2026.100405_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11605-022-05496-6","article-title":"Impact of the Affordable Care Act on presentation, treatment, and outcomes of intrahepatic cholangiocarcinoma","volume":"27","author":"Lima","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"10.1016\/j.esmogo.2026.100405_bib26","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1158\/1055-9965.EPI-25-0634","article-title":"Racial and ethnic disparities in survival among patients with cholangiocarcinoma in the United States: a systematic review and meta-analysis","volume":"34","author":"Shubin","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.esmogo.2026.100405_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5604\/01.3001.0012.0929","article-title":"Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995-2014","volume":"17","author":"Antwi","year":"2018","journal-title":"Ann Hepatol"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819826001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819826001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:45:11Z","timestamp":1789659911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819826001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"alternative-id":["S2949819826001056"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2026.100405","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Care delivery among patients with early-onset versus average-onset cholangiocarcinoma: a nationwide retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2026.100405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100405"}}